BioCatalystWatch
NRIXWorkspace / NRIX / OverviewCompany library
Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. (NRIX)

Website

Price
Market cap
Next catalystDec 13, 2026Bexobrutideg — NX-5948-301 · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Bexobrutideg

Small molecule

BTK

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Bexobrutideg

Small molecule

BTK

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Bexobrutideg

Small molecule

BTK

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Bexobrutideg

Small molecule

BTK

Upcoming / outlook

Other pipelines

Bexobrutideg

Small molecule

BTK

Bexobrutideg

Small molecule

BTK

PreINDP1P3FilingApproved
Bexobrutideg

Small molecule

BTK

PreINDP1P2P3FilingApproved

Small molecule

CBL-B

PreINDP1P2P3FilingApproved
BRAF degrader

Pan-mutant BRAF

PreINDP1P2P3FilingApproved
NRX-0305

Pan-mutant BRAF

PreINDP1P2P3FilingApproved
Aurora A degrader

AURKA

PreINDP1P2P3FilingApproved
NRX-4972

AURKA

PreINDP1P2P3FilingApproved

Partner / License out

STAT6

PreINDP1P2P3FilingApproved

STAT6

STAT6

STAT6

STAT6

Targeted protein degrader

IRAK4

PreINDP1P2P3FilingApproved
Upcoming / outlook

Targeted protein degrader

IRAK4

Targeted protein degrader

IRAK4

History / paused

Bexobrutideg

Small molecule

BTK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Small molecule

BTK × IKZF1 (Ikaros) × IKZF3 (Aiolos)

PreINDP1P2P3FilingApproved

CBL-B

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NRIX PR & News

NRIX SEC archive